+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Orphan Drugs Global Market Report 2024 - Product Thumbnail Image

Orphan Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Small Fiber Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Small Fiber Neuropathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Nrf2 Pathway Activators - Pipeline Insight, 2024 - Product Thumbnail Image

Nrf2 Pathway Activators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Loading Indicator